Hematology TimesAEs prompt EMA review of idelalisibMarch 13, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
Hematology NewsLenalidomide-dexamethasone yields similar PFS as triplet regimens in elderly multiple myeloma patientsMarch 12, 2016Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesClass of drugs could treat B-cell malignanciesMarch 12, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsHIV drug may overcome proteasome-inhibitor resistance in multiple myelomaMarch 11, 2016Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesAllele associated with poor outcome in CLLMarch 11, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology NewsFollicular lymphoma: Quantitative PET/CT measures for detecting bone marrow involvementMarch 10, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesGermline mutations linked to hematologic malignanciesMarch 10, 2016AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLMyelodysplastic SyndromeHodgkin LymphomaCML
Hematology TimesFDA lifts partial clinical hold on pidilizumabMarch 10, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesTargeting a protein to prevent malignancyMarch 7, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology TimesFDA approves ibrutinib as first-line CLL therapyMarch 5, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesStudy results support screening of childhood HL survivorsMarch 3, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology NewsIbrutinib bodes well for relapsed mantle-cell lymphomaMarch 2, 2016Mantle Cell LymphomaLymphoma & Plasma Cell DisordersMelanoma
Hematology NewsChildren’s cancer survival steadily increasingMarch 1, 2016AMLPediatricsALLCNS/Brain CancerLymphoma & Plasma Cell DisordersPatient & Survivor Care
Oncology PracticeKi-67 bests cytology, growth pattern as prognostic factor for MCLFebruary 29, 2016Lymphoma & Plasma Cell DisordersMantle Cell Lymphoma
Hematology TimesFDA approves obinutuzumab for FLFebruary 27, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
